SCHEMBL25754523

SCHEMBL25754523

COc1ccc(NC(=O)c2cccc(C#N)c2Cl)cc1S(=O)(=O)Nc1c(C)cccc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.47
MEN1 O00255 5/20 0.47
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 3/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 3/20 0.46
GAA P10253 1/20 0.46
ALOX12 P18054 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
SLC22A12 Q96S37 1/20 0.46
POLB P06746 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KCNK3 O14649 1/20 0.43
KCNK9 Q9NPC2 1/20 0.43
HPGD P15428 1/20 0.43
IDH1 O75874 3/20 0.43
PTGS2 P35354 2/20 0.43
TOP1 P11387 1/20 0.43
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25754567 0.81 KMT2A (0.50) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL23846558 0.80 POLB (0.42) KMT2AMAPTSMN1; SMN2ALDH1A1LMNA
SCHEMBL25754476 0.79 MEN1 (0.50) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL25754556 0.79 LMNA (0.49) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL23846567 0.79 MAPT (0.51) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL23846526 0.79 KMT2A (0.49) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL25754507 0.79 LMNA (0.53) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL23846413 0.78 KMT2A (0.56) KMT2AMEN1SMN1; SMN2ALDH1A1LMNA
SCHEMBL23846418 0.78 LMNA (0.48) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1
SCHEMBL23846362 0.78 SMN1; SMN2 (0.57) KMT2AMEN1MAPTSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 KMT2A 4864/4885MEN1 3902/4885MAPT 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.